Evidence map›Paper›PMID 36944627›Full record

ReviewCurrent medicinal chemistry2024

Exploring Scoring Function Space: Developing Computational Models for Drug Discovery.

Gabriela Bitencourt-Ferreira, Marcos A Villarreal, Rodrigo Quiroga, Nadezhda Biziukova, Vladimir Poroikov, Olga Tarasova, Walter F de Azevedo Junior

Abstract readReview
PubMed Publisher
In one paragraph

Review in Current medicinal chemistry, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed.

  1. Review
  2. Machine Learning to Predict CDK4 Inhibition.Methods in molecular biology (Clifton, N.J.) · 2026
    Article
  3. Neural Networks with Molegro Data Modeller.Methods in molecular biology (Clifton, N.J.) · 2026
    Article
  4. Targeting CDK9 with Molegro Virtual Docker.Methods in molecular biology (Clifton, N.J.) · 2026
    Article
  5. Differential Evolution for Docking Simulations.Methods in molecular biology (Clifton, N.J.) · 2026
    Article
  6. Molegro Data Modeller to Estimate CDK6 Inhibition.Methods in molecular biology (Clifton, N.J.) · 2026
    Article
  7. Tree-Based Methods to Predict Enzyme Inhibition.Methods in molecular biology (Clifton, N.J.) · 2026
    Article
  8. Neural Networks to Calculate CDK2 Inhibition.Methods in molecular biology (Clifton, N.J.) · 2026
    Article
  9. CDK7 as a Target for Docking Screens.Methods in molecular biology (Clifton, N.J.) · 2026
    Article
  10. Molegro Virtual Docker for Docking Screens.Methods in molecular biology (Clifton, N.J.) · 2026
    Article
  11. A Primer on SAnDReS 2.0 for Scoring Function Design.Methods in molecular biology (Clifton, N.J.) · 2026
    Article
  12. Gradient Descent to Predict Enzyme Inhibition.Methods in molecular biology (Clifton, N.J.) · 2026
    Article
  13. Elastic Net Regression to Predict CDK2 Inhibition.Methods in molecular biology (Clifton, N.J.) · 2026
    Article
  14. Hands-On Docking with Molegro Virtual Docker.Methods in molecular biology (Clifton, N.J.) · 2026
    Article
  15. Exploring the Scoring Function Space with Lasso Regression.Methods in molecular biology (Clifton, N.J.) · 2026
    Article
  16. Calculating Enzyme Inhibition with Random Forests.Methods in molecular biology (Clifton, N.J.) · 2026
    Article
  17. Combining MVD and Ridge Method to Predict CDK2 Inhibition.Methods in molecular biology (Clifton, N.J.) · 2026
    Article
  18. Molegro Data Modeller for Machine Learning.Methods in molecular biology (Clifton, N.J.) · 2026
    Article
  19. Extremely Randomized Trees to Determine Binding Affinity.Methods in molecular biology (Clifton, N.J.) · 2026
    Article
  20. Decision Tree for Prediction of Binding Affinity.Methods in molecular biology (Clifton, N.J.) · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Gabriela Bitencourt-FerreiraPontifical Catholic University of Rio Grande do Sul - PUCRS, Porto Alegre-RS, Brazil.ORCID 0000-0002-3120-8256
Marcos A VillarrealCONICET-Departamento de Matemática y Física, Instituto de Investigaciones en Fisicoquímica de Córdoba (INFIQC), Facultad de Ciencias Químicas, Universidad Nacional de Córdoba, Ciudad Universitaria, Córdoba, Argentina.ORCID 0000-0001-8223-5193
Rodrigo QuirogaCONICET-Departamento de Matemática y Física, Instituto de Investigaciones en Fisicoquímica de Córdoba (INFIQC), Facultad de Ciencias Químicas, Universidad Nacional de Córdoba, Ciudad Universitaria, Córdoba, Argentina.ORCID 0000-0001-5015-0531
Nadezhda BiziukovaInstitute of Biomedical Chemistry, Pogodinskaya Str., 10/8, Moscow, 119121, Russia.ORCID 0000-0002-2044-1327
Vladimir PoroikovInstitute of Biomedical Chemistry, Pogodinskaya Str., 10/8, Moscow, 119121, Russia.ORCID 0000-0001-7937-2621
Olga TarasovaInstitute of Biomedical Chemistry, Pogodinskaya Str., 10/8, Moscow, 119121, Russia.ORCID 0000-0002-3723-7832
Walter F de Azevedo JuniorPontifical Catholic University of Rio Grande do Sul - PUCRS, Porto Alegre-RS, Brazil.ORCID 0000-0001-8640-357X

Funding

CNPq (Brazil) Process Number: 309029/2018-0Coordenação de Aperfeiçoamento de Pessoal de Nível Superior - Brasil (CAPES) Finance Code 001Russian Foundation for Basic Research Grant no. 20-04-60285.
6 · The paper itself

Abstract

backgroundThe idea of scoring function space established a systems-level approach to address the development of models to predict the affinity of drug molecules by those interested in drug discovery.

objectiveOur goal here is to review the concept of scoring function space and how to explore it to develop machine learning models to address protein-ligand binding affinity.

methodsWe searched the articles available in PubMed related to the scoring function space. We also utilized crystallographic structures found in the protein data bank (PDB) to represent the protein space.

resultsThe application of systems-level approaches to address receptor-drug interactions allows us to have a holistic view of the process of drug discovery. The scoring function space adds flexibility to the process since it makes it possible to see drug discovery as a relationship involving mathematical spaces.

conclusionThe application of the concept of scoring function space has provided us with an integrated view of drug discovery methods. This concept is useful during drug discovery, where we see the process as a computational search of the scoring function space to find an adequate model to predict receptor-drug binding affinity.

Indexed as

Drug DiscoveryMachine LearningHumansLigandsPharmaceutical PreparationsProtein BindingProteinsLigandsPharmaceutical PreparationsProteinsdrug discoverymachine learningprotein-ligand interactionsprotein spaceScoring function spacesystems biology.

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.